SAMN38855664
External Id
Sanofi
INSDC center name
2023-12-15T00:00:00Z
INSDC first public
2023-12-15T10:21:32.983Z
INSDC last update
SRS19870207
INSDC secondary accession
live
INSDC status
Human
NCBI submission model
Human.1.0
NCBI submission package
SRS19870207
SRA accession
29
age
Dr. John Tisdale, National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, USA
biomaterial_provider
Erythroid differentiated CD34+ cells
cell_type
2018
collection_date
Erythroid colonies from single clones were derived from plerixafor-mobilized HSC treated with Zinc Finger Nucleases targeting the BCL11A enhancer. CD34+ HSC were collected from a donor with sickle cell disease.
description
Clone_SCD3_33
engrafted_mice
USA
geo_loc_name
Sickle Cell Disease
health_state
SCD003
isolate
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Mobilized peripheral blood
tissue
Erythroid colony from a single clone derived from plerixafor mobilized HSC treated with BCL11A ZFN
title
BCL11A ZFN
treatment